Dr Yu-Wei Lin is Senior Director of Pharmacometrics and APAC Quantitative Sciences Solutions Team Lead at Certara. He is an experienced pharmacometrician with expertise across population PK/PD, exposure–response, translational modelling, and model-informed drug development. His work spans oncology, monoclonal antibodies, antibody–drug conjugates, infectious diseases, and complex biologics, supporting dose optimization, regulatory strategy, and clinical development decision-making.

Dr Lin has led and contributed to global modelling and simulation programs across early- and late-stage development, including ADC-related quantitative pharmacology strategies. In addition to his role at Certara, he holds academic appointments and maintains an active research portfolio in antimicrobial PK/PD, AI-enabled pharmacometrics, and translational drug development.